yes i take peptides · shopping companion
Sermorelin
Category · For EnergyStatus · RXCitations · 60WADA-banned · IGF-1 Elevation
The verdict
Depends — sermorelin has the cleanest GH-secretagogue safety profile but the FDA pulled it from the US market for commercial reasons in 2008, and the current supply is compounded or RUO with all the supply-side instability that implies.
By source — cost, legality, risk
- Brand — Geref (discontinued)Not availableNone active — Geref discontinued 2008 for commercial reasonsNo current FDA-approved sermorelin brand; the dominant clinical channel is compounded.
- Compounded 503A pharmacy$150–$400/moRx · the dominant clinical channelLowest. Pharmacy-grade; sermorelin has the longest clinical-use history of the GH-secretagogue family.
- RUO research peptide$30–$100/moSold 'for research only'Highest. The cheap-fallback; identity-failures vs CJC-1295 or Mod GRF 1-29 are documented.
- Gray-market raw$10–$25/moUnregulated overseas importSame upstream synthesis as RUO. Crypto/Wise pay; one box covers many months.
Sources · top 5 of 60
- 01Rahman OF, et al. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews. 2026;10(1). PMID: 41490200.
- 02Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?. Clinical interventions in aging. 2006;1(4):307-8. PMID: 18046908.
- 03Memdouh S, et al. Advances in the detection of growth hormone releasing hormone synthetic analogs. Drug testing and analysis. 2021;13(11-12):1871-1887. PMID: 34665524.
- 04Chang Y, et al. A potentially effective drug for patients with recurrent glioma: sermorelin. Annals of translational medicine. 2021;9(5):406. PMID: 33842627.
- 05Prakash A, et al. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. 1999;12(2):139-57. PMID: 18031173.